Home > PS Ratio > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of BALAXI PHARMACEUTICALS is 1.42.

Share Price ₹70.9Mar 07,2025
Market Cap ₹391.5 Cr
Sales-TTM₹276.1 CrTTM-Consolidated Results
Price/Sales1.42xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of BALAXI PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of BALAXI PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹391.5 Cr] as on Mar 07,2025

(/) Sales [ ₹276.1 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 1.42x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay '1.42 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of BALAXI PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of BALAXI PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of BALAXI PHARMACEUTICALS


PS Ratio Performance Analysis for BALAXI PHARMACEUTICALS

- BALAXI PHARMACEUTICALS 's latest p/e ratio is 1.42x.

- BALAXI PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.80x.

- BALAXI PHARMACEUTICALS 's operated at median p/e ratio of 1.62x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 2.27x.

- BALAXI PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2022 of 1.26x.


How does BALAXI PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Trading Industry?

Peer Comparison (Trading Industry)Sales (Cr)PS RatioMarket Cap (Cr)
BALAXI PHARMACEUTICALS 276.11.42391.5
ADANI ENTERPRISES LTD100,109.02.57257,302.0
REDINGTON LTD95,327.40.2019,176.9
MMTC LTD3.12,546.617,894.5
HONASA CONSUMER LTD2,004.53.527,061.4
LLOYDS ENTERPRISES LTD1,332.74.075,419.3
ENTERO HEALTHCARE SOLUTIONS LTD4,790.91.135,412.8
OPTIEMUS INFRACOM LTD1,930.81.983,817.8
POLO QUEEN INDUSTRIAL & FINTECH LTD92.727.692,565.1
MSTC LTD541.65.983,240.5
SG MART LTD5,582.80.643,596.7

Trading Industry Benchmark (Top 10) PS Analysis vs BALAXI PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 0.20x
Max industry PS 2,546.61x
Median industry PS 2.57x
Average industry PS 235.98x



You may also like the below Video Courses